DEXCOM, INC. Comprehensive Income
DEXCOM, INC. (DXCM) reported Comprehensive Income of $232.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-07-30
- DEXCOM, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $232.90M, a 10.83% decline year-over-year.
- DEXCOM, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $190.70M, a 64.97% increase year-over-year.
- DEXCOM, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $300.80M, a 274.60% increase year-over-year.
- DEXCOM, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $281.70M, a 19.36% increase year-over-year.
- DEXCOM, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $959.30M, a 64.01% increase from fiscal 2024.
- DEXCOM, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $584.90M, a 9.04% increase from fiscal 2023.
- DEXCOM, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $536.40M, a 62.99% increase from fiscal 2022.
- DEXCOM, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $329.10M, a 53.64% increase from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $232.90M 10-Q · filed 2026-07-30 | $423.60M 10-Q · filed 2026-07-30 | $724.40M derived: sum of 3 quarters · filed 2026-07-30 | $1.01B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $190.70M 10-Q · filed 2026-04-30 | $491.50M derived: sum of 2 quarters · filed 2026-04-30 | $773.20M derived: sum of 3 quarters · filed 2026-04-30 | $1.03B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $300.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $582.50M derived: sum of 2 quarters · filed 2026-02-12 | $843.70M derived: sum of 3 quarters · filed 2026-07-30 | $959.30M 10-K · filed 2026-02-12 | ||||
| 2025-09-30 | $281.70M 10-Q · filed 2025-10-30 | $542.90M derived: sum of 2 quarters · filed 2026-07-30 | $658.50M 10-Q · filed 2025-10-30 | $738.80M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $261.20M 10-Q · filed 2026-07-30 | $376.80M 10-Q · filed 2026-07-30 | $457.10M derived: sum of 3 quarters · filed 2026-07-30 | $693.10M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $115.60M 10-Q · filed 2026-04-30 | $195.90M derived: sum of 2 quarters · filed 2026-04-30 | $431.90M derived: sum of 3 quarters · filed 2026-04-30 | $574.70M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $80.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $316.30M derived: sum of 2 quarters · filed 2026-02-12 | $459.10M derived: sum of 3 quarters · filed 2026-02-12 | $584.90M 10-K · filed 2026-02-12 | ||||
| 2024-09-30 | $236.00M 10-Q · filed 2025-10-30 | $378.80M derived: sum of 2 quarters · filed 2025-10-30 | $504.60M 10-Q · filed 2025-10-30 | $779.80M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-06-30 | $142.80M 10-Q · filed 2025-07-30 | $268.60M 10-Q · filed 2025-07-30 | $543.80M derived: sum of 3 quarters · filed 2026-02-12 | $658.20M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-03-31 | $125.80M 10-Q · filed 2025-05-01 | $401.00M derived: sum of 2 quarters · filed 2026-02-12 | $515.40M derived: sum of 3 quarters · filed 2026-02-12 | $608.50M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2023-12-31 | $275.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $389.60M derived: sum of 2 quarters · filed 2026-02-12 | $482.70M derived: sum of 3 quarters · filed 2026-02-12 | $536.40M 10-K · filed 2026-02-12 | ||||
| 2023-09-30 | $114.40M 10-Q · filed 2024-10-24 | $207.50M derived: sum of 2 quarters · filed 2024-10-24 | $261.20M 10-Q · filed 2024-10-24 | $382.50M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | $93.10M 10-Q · filed 2024-07-25 | $146.80M 10-Q · filed 2024-07-25 | $268.10M derived: sum of 3 quarters · filed 2025-02-18 | $351.20M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | $53.70M 10-Q · filed 2024-04-25 | $175.00M derived: sum of 2 quarters · filed 2025-02-18 | $258.10M derived: sum of 3 quarters · filed 2025-02-18 | $292.10M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | $121.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $204.40M derived: sum of 2 quarters · filed 2025-02-18 | $238.40M derived: sum of 3 quarters · filed 2025-02-18 | $329.10M 10-K · filed 2025-02-18 | ||||
| 2022-09-30 | $83.10M 10-Q · filed 2023-10-26 | $117.10M derived: sum of 2 quarters · filed 2023-10-26 | $207.80M 10-Q · filed 2023-10-26 | $201.60M derived: sum of 4 quarters · filed 2024-02-08 | ||||
| 2022-06-30 | $34.00M 10-Q · filed 2023-07-27 | $124.70M 10-Q · filed 2023-07-27 | $118.50M derived: sum of 3 quarters · filed 2024-02-08 | $204.40M derived: sum of 4 quarters · filed 2024-02-08 | ||||
| 2022-03-31 | $90.70M 10-Q · filed 2023-04-27 | $84.50M derived: sum of 2 quarters · filed 2024-02-08 | $170.40M derived: sum of 3 quarters · filed 2024-02-08 | $248.70M derived: sum of 4 quarters · filed 2024-02-08 | ||||
| 2021-12-31 | -$6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $79.70M derived: sum of 2 quarters · filed 2024-02-08 | $158.00M derived: sum of 3 quarters · filed 2024-02-08 | $214.20M 10-K · filed 2024-02-08 | $152.00M 10-K · filed 2022-02-14 | |||
| 2021-09-30 | $85.90M 10-Q · filed 2022-10-27 | $69.50M 10-Q · filed 2021-10-28 | $164.20M derived: sum of 2 quarters · filed 2022-10-27 | $220.40M 10-Q · filed 2022-10-27 | $172.30M 10-Q · filed 2021-10-28 | $632.10M derived: sum of 4 quarters · filed 2023-02-09 | ||
| 2021-06-30 | $78.30M 10-Q · filed 2022-07-28 | $62.80M 10-Q · filed 2021-07-29 | $134.50M 10-Q · filed 2022-07-28 | $102.80M 10-Q · filed 2021-07-29 | $546.20M derived: sum of 3 quarters · filed 2023-02-09 | $617.70M derived: sum of 4 quarters · filed 2023-02-09 | ||
| 2021-03-31 | $56.20M 10-Q · filed 2022-04-28 | $40.00M 10-Q · filed 2021-04-29 | $467.90M derived: sum of 2 quarters · filed 2023-02-09 | $539.40M derived: sum of 3 quarters · filed 2023-02-09 | $585.50M derived: sum of 4 quarters · filed 2023-02-09 | |||
| 2020-12-31 | $411.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $483.20M derived: sum of 2 quarters · filed 2023-02-09 | $529.30M derived: sum of 3 quarters · filed 2023-02-09 | $550.60M 10-K · filed 2023-02-09 | $494.50M 10-K · filed 2021-02-11 | |||
| 2020-09-30 | $71.50M 10-Q · filed 2021-10-28 | $117.60M derived: sum of 2 quarters · filed 2021-10-28 | $138.90M 10-Q · filed 2021-10-28 | $232.90M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-06-30 | $46.10M 10-Q · filed 2021-07-29 | $67.40M 10-Q · filed 2021-07-29 | $161.40M derived: sum of 3 quarters · filed 2022-02-14 | $206.20M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-03-31 | $21.30M 10-Q · filed 2021-04-29 | $115.30M derived: sum of 2 quarters · filed 2022-02-14 | $160.10M derived: sum of 3 quarters · filed 2022-02-14 | $150.00M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2019-12-31 | $94.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $138.80M derived: sum of 2 quarters · filed 2022-02-14 | $128.70M derived: sum of 3 quarters · filed 2022-02-14 | $101.90M 10-K · filed 2022-02-14 | ||||
| 2019-09-30 | $44.80M 10-Q · filed 2020-10-27 | $34.70M derived: sum of 2 quarters · filed 2020-10-27 | $7.90M 10-Q · filed 2020-10-27 | -$170.00M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | -$10.10M 10-Q · filed 2020-07-28 | -$36.90M 10-Q · filed 2020-07-28 | -$214.80M derived: sum of 3 quarters · filed 2021-02-11 | -$167.20M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | -$26.80M 10-Q · filed 2020-04-28 | -$204.70M derived: sum of 2 quarters · filed 2021-02-11 | -$157.10M derived: sum of 3 quarters · filed 2021-02-11 | -$123.30M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | -$177.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | -$130.30M derived: sum of 2 quarters · filed 2021-02-11 | -$96.50M derived: sum of 3 quarters · filed 2021-02-11 | -$123.00M 10-K · filed 2021-02-11 | ||||
| 2018-09-30 | $47.60M 10-Q · filed 2019-11-06 | $81.40M derived: sum of 2 quarters · filed 2019-11-06 | $54.90M 10-Q · filed 2019-11-06 | $45.10M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | $33.80M 10-Q · filed 2019-07-31 | $7.30M 10-Q · filed 2019-07-31 | -$2.50M derived: sum of 3 quarters · filed 2020-02-13 | -$5.10M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | -$26.50M 10-Q · filed 2019-05-01 | -$36.30M derived: sum of 2 quarters · filed 2020-02-13 | -$38.90M derived: sum of 3 quarters · filed 2020-02-13 | -$36.30M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | -$9.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$12.40M derived: sum of 2 quarters · filed 2020-02-13 | -$9.80M derived: sum of 3 quarters · filed 2020-02-13 | -$51.80M 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | -$2.60M 10-Q · filed 2018-11-06 | $0.00 derived: sum of 2 quarters · filed 2018-11-06 | -$42.00M 10-Q · filed 2018-11-06 | -$49.70M derived: sum of 4 quarters · filed 2019-02-21 | ||||
| 2017-06-30 | $2.60M 10-Q · filed 2018-08-01 | -$39.40M 10-Q · filed 2018-08-01 | -$47.10M derived: sum of 3 quarters · filed 2019-02-21 | -$65.90M derived: sum of 4 quarters · filed 2019-02-21 | ||||
| 2017-03-31 | -$42.00M 10-Q · filed 2018-05-02 | -$49.70M derived: sum of 2 quarters · filed 2019-02-21 | -$68.50M derived: sum of 3 quarters · filed 2019-02-21 | -$89.10M derived: sum of 4 quarters · filed 2019-02-21 | ||||
| 2016-12-31 | -$7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | -$26.50M derived: sum of 2 quarters · filed 2019-02-21 | -$47.10M derived: sum of 3 quarters · filed 2019-02-21 | -$66.30M 10-K · filed 2019-02-21 | ||||
| 2016-09-30 | -$18.80M 10-Q · filed 2017-11-01 | -$39.40M derived: sum of 2 quarters · filed 2017-11-01 | -$58.60M 10-Q · filed 2017-11-01 | -$57.10M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | -$20.60M 10-Q · filed 2017-08-01 | -$39.80M 10-Q · filed 2017-08-01 | -$38.30M derived: sum of 3 quarters · filed 2018-02-27 | -$80.80M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | -$19.20M 10-Q · filed 2017-05-02 | -$17.70M derived: sum of 2 quarters · filed 2018-02-27 | -$60.20M derived: sum of 3 quarters · filed 2018-02-27 | -$63.90M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$41.00M derived: sum of 2 quarters · filed 2018-02-27 | -$44.70M derived: sum of 3 quarters · filed 2018-02-27 | -$57.80M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | -$42.50M 10-Q · filed 2016-11-01 | -$46.20M derived: sum of 2 quarters · filed 2016-11-01 | -$59.30M 10-Q · filed 2016-11-01 | -$58.00M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | -$3.70M 10-Q · filed 2016-08-02 | -$16.80M 10-Q · filed 2016-08-02 | -$15.50M derived: sum of 3 quarters · filed 2017-02-28 | -$20.60M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | -$13.10M 10-Q · filed 2016-04-27 | -$11.80M derived: sum of 2 quarters · filed 2017-02-28 | -$16.90M derived: sum of 3 quarters · filed 2017-02-28 | -$22.90M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$3.80M derived: sum of 2 quarters · filed 2017-02-28 | -$9.80M derived: sum of 3 quarters · filed 2017-02-28 | -$22.40M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | -$5.10M 10-Q · filed 2015-11-04 | -$11.10M derived: sum of 2 quarters · filed 2015-11-04 | -$23.70M 10-Q · filed 2015-11-04 | -$26.20M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-06-30 | -$6.00M 10-Q · filed 2015-08-05 | -$18.50M 10-Q · filed 2015-08-05 | -$21.10M derived: sum of 3 quarters · filed 2016-02-23 | -$27.10M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-03-31 | -$12.50M 10-Q · filed 2015-04-29 | -$15.10M derived: sum of 2 quarters · filed 2016-02-23 | -$21.10M derived: sum of 3 quarters · filed 2016-02-23 | -$31.20M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2013-12-31 | -$2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | -$8.60M derived: sum of 2 quarters · filed 2016-02-23 | -$18.70M derived: sum of 3 quarters · filed 2016-02-23 | -$29.80M 10-K · filed 2016-02-23 | ||||
| 2013-09-30 | -$6.00M 10-Q · filed 2014-11-06 | -$16.10M derived: sum of 2 quarters · filed 2014-11-06 | -$27.20M 10-Q · filed 2014-11-06 | -$35.70M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | -$10.10M 10-Q · filed 2014-08-06 | -$21.20M 10-Q · filed 2014-08-06 | -$29.70M derived: sum of 3 quarters · filed 2015-02-25 | -$47.00M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | -$11.10M 10-Q · filed 2014-05-01 | -$19.60M derived: sum of 2 quarters · filed 2015-02-25 | -$36.90M derived: sum of 3 quarters · filed 2015-02-25 | -$51.60M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | -$8.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | -$25.80M derived: sum of 2 quarters · filed 2015-02-25 | -$40.50M derived: sum of 3 quarters · filed 2015-02-25 | -$54.50M 10-K · filed 2015-02-25 | ||||
| 2012-09-30 | -$17.30M 10-Q · filed 2013-11-06 | -$17.27M 10-Q · filed 2012-11-01 | -$32.00M derived: sum of 2 quarters · filed 2013-11-06 | -$46.00M 10-Q · filed 2013-11-06 | -$46.03M 10-Q · filed 2012-11-01 | -$58.38M derived: sum of 4 quarters · filed 2014-02-20 | ||
| 2012-06-30 | -$14.70M 10-Q · filed 2013-08-07 | -$14.68M 10-Q · filed 2012-08-06 | -$28.80M 10-Q · filed 2013-08-07 | -$28.76M 10-Q · filed 2012-08-06 | -$41.08M derived: sum of 3 quarters · filed 2014-02-20 | -$54.35M derived: sum of 4 quarters · filed 2014-02-20 | ||
| 2012-03-31 | -$14.10M 10-Q · filed 2013-05-01 | -$14.09M 10-Q · filed 2012-05-02 | -$26.38M derived: sum of 2 quarters · filed 2014-02-20 | -$39.65M derived: sum of 3 quarters · filed 2014-02-20 | -$47.03M derived: sum of 4 quarters · filed 2014-02-20 | |||
| 2011-12-31 | -$12.28M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | -$25.55M derived: sum of 2 quarters · filed 2014-02-20 | -$32.93M derived: sum of 3 quarters · filed 2014-02-20 | -$44.80M 10-K · filed 2014-02-20 | -$44.76M 10-K · filed 2012-02-23 | |||
| 2011-09-30 | -$13.27M 10-Q · filed 2012-11-01 | -$20.66M derived: sum of 2 quarters · filed 2012-11-01 | -$32.52M 10-Q · filed 2012-11-01 | |||||
| 2011-06-30 | -$7.38M 10-Q · filed 2012-08-06 | -$19.25M 10-Q · filed 2012-08-06 | ||||||
| 2011-03-31 | -$11.87M 10-Q · filed 2012-05-02 | |||||||
| 2010-12-31 | -$55.20M 10-K · filed 2013-02-21 | -$55.22M 10-K · filed 2012-02-23 | ||||||
| 2009-12-31 | -$53.59M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |